Article
Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.
Neuropsychobiology - 1 Jan 2002
Sato Kazuhiro, Yoshida Keizo, Takahashi Hitoshi, Ito Kenichi, Kamata Mitsuhiro, Higuchi Hisashi, Shimizu Tetsuo, Itoh Kunihiko, Inoue Kazuyuki, Tezuka Takehiko, Suzuki Toshio, Ohkubo Taashi, Sugawara Kazunobu, Otani Koichi
Abstract excerpt
Genetic polymorphism of the serotonin 5-HT(2A) receptor seems to be associated with therapeutic response to selective serotonin reuptake inhibitors (SSRIs). The present study investigated whether a novel -1438G/A polymorphism in the promoter region of the 5-HT(2A )receptor gene is associated with therapeutic response to fluvoxamine (an SSRI) in 66 Japanese patients with major depressive disorder. Fluvoxamine (50...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
